Literature DB >> 35859875

Design, Synthesis, and Biological Activity of l-1'-Homologated Adenosine Derivatives.

Mai Nguyen1, Seungchan An2,3, Yen Nguyen1, Young Eum Hyun2, Hongseok Choi2, Linh Pham1, Jung-Ae Kim4, Minsoo Noh2,3, Gyudong Kim1, Lak Shin Jeong2.   

Abstract

On the basis of the previously reported polypharmacological profile of truncated d-1'-homologated adenosine derivatives [J. Med. Chem.2020, 63, 16012], the l-nucleoside analogues were synthesized using computer-aided design and evaluated for biological activity. The target molecules were synthesized from d-ribose via the key intramolecular cyclization of the monotosylate and Mitsunobu condensation. The peroxisome proliferator-activated receptor (PPAR) binding activities of l-nucleoside analogue 2d (K i = 4.3 μM for PPARγ and 1.0 μM for PPARδ) were significantly improved in comparison with those of the d-nucleoside compound 1 (11.9 and 2.7 μM, respectively). In addition, the l-nucleosides showed more potent adiponectin-secretion-promoting activity than the d-nucleoside analogues.
© 2022 American Chemical Society.

Entities:  

Year:  2022        PMID: 35859875      PMCID: PMC9290037          DOI: 10.1021/acsmedchemlett.2c00159

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN: 1948-5875            Impact factor:   4.632


  17 in total

Review 1.  Antivirals at the mirror: the lack of stereospecificity of some viral and human enzymes offers novel opportunities in antiviral drug development.

Authors:  Federico Focher; Silvio Spadari; Giovanni Maga
Journal:  Curr Drug Targets Infect Disord       Date:  2003-03

Review 2.  L-nucleoside enantiomers as antivirals drugs: a mini-review.

Authors:  Christophe Mathé; Gilles Gosselin
Journal:  Antiviral Res       Date:  2006-05-23       Impact factor: 5.970

Review 3.  Exploration and Development of PPAR Modulators in Health and Disease: An Update of Clinical Evidence.

Authors:  Hong Sheng Cheng; Wei Ren Tan; Zun Siong Low; Charlie Marvalim; Justin Yin Hao Lee; Nguan Soon Tan
Journal:  Int J Mol Sci       Date:  2019-10-11       Impact factor: 5.923

4.  Electrostatic Complementarity as a Fast and Effective Tool to Optimize Binding and Selectivity of Protein-Ligand Complexes.

Authors:  Matthias R Bauer; Mark D Mackey
Journal:  J Med Chem       Date:  2019-03-13       Impact factor: 7.446

5.  Structural basis for specific ligation of the peroxisome proliferator-activated receptor δ.

Authors:  Chyuan-Chuan Wu; Thomas J Baiga; Michael Downes; James J La Clair; Annette R Atkins; Stephane B Richard; Weiwei Fan; Theresa A Stockley-Noel; Marianne E Bowman; Joseph P Noel; Ronald M Evans
Journal:  Proc Natl Acad Sci U S A       Date:  2017-03-20       Impact factor: 11.205

6.  Predicting new molecular targets for known drugs.

Authors:  Michael J Keiser; Vincent Setola; John J Irwin; Christian Laggner; Atheir I Abbas; Sandra J Hufeisen; Niels H Jensen; Michael B Kuijer; Roberto C Matos; Thuy B Tran; Ryan Whaley; Richard A Glennon; Jérôme Hert; Kelan L H Thomas; Douglas D Edwards; Brian K Shoichet; Bryan L Roth
Journal:  Nature       Date:  2009-11-01       Impact factor: 49.962

7.  The influence of intramolecular sulfur-lone pair interactions on small-molecule drug design and receptor binding.

Authors:  B M Hudson; E Nguyen; D J Tantillo
Journal:  Org Biomol Chem       Date:  2016-04-06       Impact factor: 3.876

8.  Structural Basis for the Enhanced Anti-Diabetic Efficacy of Lobeglitazone on PPARγ.

Authors:  Jun Young Jang; Hwan Bae; Yong Jae Lee; Young Il Choi; Hyun-Jung Kim; Seung Bum Park; Se Won Suh; Sang Wan Kim; Byung Woo Han
Journal:  Sci Rep       Date:  2018-01-08       Impact factor: 4.379

Review 9.  Recent Advances in the Chemical Synthesis and Evaluation of Anticancer Nucleoside Analogues.

Authors:  Mieke Guinan; Caecilie Benckendorff; Mark Smith; Gavin J Miller
Journal:  Molecules       Date:  2020-04-28       Impact factor: 4.411

10.  Novel L-nucleoside analogue, 5-fluorotroxacitabine, displays potent efficacy against acute myeloid leukemia.

Authors:  Aniket Bankar; Thirushi Piyumika Siriwardena; Biljana Rizoska; Christina Rydergård; Helen Kylefjord; Vilma Rraklli; Anders Eneroth; Pedro Pinho; Stefan Norin; Johan Bylund; Sara Moses; Richard Bethell; Simon Kavanagh; Neil Maclean; Marcela Gronda; Xiaoming Wang; Rose Hurren; Mark D Minden; Paul Targett-Adams; Aaron D Schimmer; Mark Albertella
Journal:  Haematologica       Date:  2021-02-01       Impact factor: 9.941

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.